Analysis of hormone receptor status in primary and recurrent breast cancer via data mining pathology reports

被引:6
|
作者
Chang, Kai-Po [3 ,4 ]
Chu, Yen-Wei [1 ,2 ]
Wang, John [3 ]
机构
[1] Natl Chung Hsing Univ, Inst Mol Biol, Biotechnol Ctr, Agr Biotechnol Ctr, Taichung 402, Taiwan
[2] Natl Chung Hsing Univ, Inst Genom & Bioinformat, Taichung 402, Taiwan
[3] China Med Univ Hosp, Dept Pathol, Taichung 404, Taiwan
[4] Natl Chung Hsing Univ, PhD Program Med Biotechnol, Taichung 402, Taiwan
来源
OPEN MEDICINE | 2019年 / 14卷 / 01期
关键词
Breast cancer; Hormone receptor; Primary cancer; Recurrent cancer; Text mining; ESTROGEN-RECEPTOR; PROGESTERONE-RECEPTOR; ENDOCRINE THERAPY; TEXT; IMMUNOHISTOCHEMISTRY; RECOMMENDATIONS; CLASSIFICATION;
D O I
10.1515/med-2019-0013
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Hormone receptors of breast cancer, such as estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (Her-2), are important prognostic factors for breast cancer. Objective: The current study aimed to develop a method to retrieve the statistics of hormone receptor expression status, documented in pathology reports, given their importance in research for primary and recurrent breast cancer, and quality management of pathology laboratories. Method: A two-stage text mining approach via regular expression-based word/phrase matching, was developed to retrieve the data. Results: The method achieved a sensitivity of 98.8%, 98.7% and 98.4% for extraction of ER, PR, and Her-2 results. The hormone expression status from 3679 primary and 44 recurrent breast cancer cases was successfully retrieved with the method. Statistical analysis of these data showed that the recurrent disease had a significantly lower positivity rate for ER (54.5% vs 76.5%, p=0.001278) than primary breast cancer and a higher positivity rate for Her-2 (48.8% vs 16.2%, p=9.79e-8). These results corroborated the previous literature. Conclusion: Text mining on pathology reports using the developed method may benefit research of primary and recurrent breast cancer.
引用
收藏
页码:91 / 98
页数:8
相关论文
共 50 条
  • [1] Development of a Novel Tool for the Retrieval and Analysis of Hormone Receptor Expression Characteristics in Metastatic Breast Cancer via Data Mining on Pathology Reports
    Chang, Kai-Po
    Wang, John
    Chang, Chi-Chang
    Chu, Yen-Wei
    BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [2] Prognostic Impact of Discordance in Hormone Receptor Status Between Primary and Recurrent Sites in Patients With Recurrent Breast Cancer
    Shiino, Sho
    Kinoshita, Takayuki
    Yoshida, Masayuki
    Jimbo, Kenjiro
    Asaga, Sota
    Takayama, Shin
    Tsuda, Hitoshi
    CLINICAL BREAST CANCER, 2016, 16 (04) : E133 - E140
  • [3] Clinicopathological characteristics and prognostic analysis of breast cancer with a hormone receptor status of ER(-)/PR(+)
    Wang, Xinli
    Xue, Yan
    FRONTIERS IN ENDOCRINOLOGY, 2023, 14
  • [4] Assessment of hormone receptor status in breast cancer
    Horii, Rie
    Akiyama, Futoshi
    Ito, Yoshinori
    Iwase, Takuji
    PATHOLOGY INTERNATIONAL, 2007, 57 (12) : 784 - 790
  • [5] Socioeconomic disparities and breast cancer hormone receptor status
    Abegail A. Andaya
    Lindsey Enewold
    Marie-Josèphe Horner
    Ismail Jatoi
    Craig D. Shriver
    Kangmin Zhu
    Cancer Causes & Control, 2012, 23 : 951 - 958
  • [6] Socioeconomic disparities and breast cancer hormone receptor status
    Andaya, Abegail A.
    Enewold, Lindsey
    Horner, Marie-Josephe
    Jatoi, Ismail
    Shriver, Craig D.
    Zhu, Kangmin
    CANCER CAUSES & CONTROL, 2012, 23 (06) : 951 - 958
  • [7] Influences of adjuvant treatments in hormone receptor positive breast cancer on receptor conversion in recurrent breast cancer
    Stueber, Tanja Nadine
    Weiss, Claire Rachel
    Woeckel, Achim
    Haeusler, Sebastian
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2019, 299 (02) : 533 - 541
  • [8] Differences in the Receptor Status between Primary and Recurrent Breast Cancer - The Frequency of and the Reasons for Discordance
    Heitz, Florian
    Barinoff, Jana
    du Bois, Ondra
    Hils, Rita
    Fisseler-Eckhoff, Annette
    Harter, Philipp
    Heitz, Julia
    Willenbrock, Klaus
    Traut, Alexander
    du Bois, Andreas
    ONCOLOGY, 2013, 84 (06) : 319 - 325
  • [9] Risk of contralateral second primary breast cancer according to hormone receptor status in Germany
    Carsten Rusner
    Katharina Wolf
    Ulrike Bandemer-Greulich
    Jutta Engel
    Christa Stegmaier
    Bernd Holleczek
    Gabriele Schubert-Fritschle
    Anett Tillack
    Andreas Stang
    Breast Cancer Research, 16
  • [10] Hormone receptor status of a first primary breast cancer predicts contralateral breast cancer risk in the WECARE study population
    Reiner, Anne S.
    Lynch, Charles F.
    Sisti, Julia S.
    John, Esther M.
    Brooks, Jennifer D.
    Bernstein, Leslie
    Knight, Julia A.
    Hsu, Li
    Concannon, Patrick
    Mellemkjaer, Lene
    Tischkowitz, Marc
    Haile, Robert W.
    Shen, Ronglai
    Malone, Kathleen E.
    Woods, Meghan
    Liang, Xiaolin
    Morrow, Monica
    Bernstein, Jonine L.
    BREAST CANCER RESEARCH, 2017, 19